16–18 October, Helsinki, Finland

i-FACTOR – Cerapedics

www.cerapedics.comAchtung Link öffnet sich in einem neuen Fenster

Cerapedics is an orthobiologics company focused on developing and commercializing novel bone grafts that enhance and accelerate bone growth in a variety of orthopaedic procedures. i-FACTOR Peptide Enhanced Bone Graft, the company's lead product, is the only biologic bone graft that utilizes a synthetic small peptide (P-15) bound to an anorganic bone mineral (ABM). i-FACTOR is also the only FDA approved (PMA received November 2015) biologic bone graft for use in cervical interbody fusion. The novel “Attract, Attach, Activate” mechanism of action enhances the body’s natural bone healing process, resulting in bone formation that is predictably bound to the surface of the bone graft.

© EUROSPINE, the Spine Society of Europe - website by bestview gmbh page last updated on 26.03.2019